[First and second generation cephalosporins].
Auvergnat
J C
JC
D002511:Cephalosporins / Q000009:adverse effects / Q000145:classification* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004066:Digestive System Diseases / Q000139:chemically induced; D004342:Drug Hypersensitivity; D006402:Hematologic Diseases / Q000139:chemically induced; D007676:Kidney Failure, Chronic / Q000139:chemically induced
D002511:Cephalosporins
Céphalosporines de 1re et 2e génération.